Back to Search
Start Over
To Activate the Cath Lab?
- Source :
-
Internal Medicine Alert . 12/15/2023, Vol. 45 Issue 23, p1-8. 8p. - Publication Year :
- 2023
-
Abstract
- The article focuses on the U.S. Food and Drug Administration approval of tirzepatide for chronic weight management, previously approved for type 2 diabetes. Topics discussed include tirzepatide's dual action on GLP-1 and GIP receptors, potential advantages in weight reduction, and potential disadvantages such as Boxed Warning for thyroid C-cell tumors and adverse reactions.
Details
- Language :
- English
- ISSN :
- 0195315X
- Volume :
- 45
- Issue :
- 23
- Database :
- Academic Search Index
- Journal :
- Internal Medicine Alert
- Publication Type :
- Periodical
- Accession number :
- 174182476